Device Dossier
LIAISON XL MUREX HBsAg Quant - Hepatitis B virus surface antigen IVD, kit, chemiluminescent immunoassay
Device Dossier for LIAISON XL MUREX HBsAg Quant - Hepatitis B virus surface antigen IVD, kit, chemiluminescent immunoassay (Hepatitis B virus surface…
Intended purpose
For the quantitative determination of Hepatitis B surface Antigen (HBsAg) in human serum and plasma samples, including specimens collected up to 24 hours post-mortem (non-heart beating).
Functional description
LIAISON® XL MUREX HBsAg Quant assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of hepatitis B surface antigen (HBsAg) in human serum or plasma samples.